MPM BIOIMPACT
MPM ASSET MANAGEMENT LLC Legal Name
Adviser information for MPM BIOIMPACT last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Limited Liability Company |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Delaware, United States |
Employees
| Total Number of Employees | 50 |
|---|---|
| Investment Advisory/Research | 34 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 0 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 2 |
RAUM
| Provides Management of Securities Portfolios | Yes |
|---|
| Type | Accounts | RAUM |
|---|---|---|
| Discretionary | 27 | $3.3B |
| Non-Discretionary | 0 | $0 |
| Total | 27 | $3.3B |
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 27 | $3.3B |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 0 | $0 |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 43 |
Services
| Advisory Services | Portfolio management for pooled investment vehicles |
|---|---|
| Compensation | % of AUMPerformance-based feesCARRIED INTEREST |
Principal Office
399 BOYLSTON STREETSUITE 1100
BOSTON
MA
United States
Monday - Friday, 9 AM TO 5 PM
Tel: 617-425-9200, Fax: 617-425-9201
Chief Compliance Officer
BRENDAN FUREY
399 BOYLSTON STREET
SUITE 1100
BOSTON
MA
United States
Tel:
617-425-9203
Fax:
617-425-9201
B*****@*************M
(Full email address available in API data)
Regulatory Contact
ELAINE BEAULIEU
SR. COMPLIANCE ASSOCIATE
399 BOYLSTON STREET
SUITE 1100
BOSTON
MA
United States
Tel:
617-410-4773
E********@*************M
(Full email address available in API data)
Industry Affiliates
| BIOIMPACT EQUITIES LLC | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| MPM BIOVENTURES 2014 GP LLC | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| MPM BIOVENTURES 2014 NVS STRATEGIC FUND GP LLC | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| MPM BIOVENTURES 2018 GP LLC | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| MPM BIOVENTURES 2022 GP LLC | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| MPM BIOVENTURES IV GP LLC | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| MPM BIOVENTURES V GP LLC | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| MPM BIOVENTURES V NVS STRATEGIC FUND GP LLC | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| MPM BIOVENTURES V, GP LLC | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| MPM ONCOLOGY INNOVATIONS FUND GP LLC | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| MPM ONCOLOGY INVESTMENTS 2 LLC | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| ONCOLOGY IMPACT FUND (CAYMAN) MANAGEMENT L.P. | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| ONCOLOGY INVESTORS OF TEXAS GP LLC | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| BIOIMPACT EQUITIES FUND, LP | Hedge Fund | $153.9M | $1.0M | 40 |
| BIOIMPACT EQUITIES MASTER FUND, LP | Hedge Fund | $99.0M | $1.0M | 11 |
| MPM ASSET MANAGEMENT INVESTORS BV4 LLC | Venture Capital Fund | $3.3M | $0.0M | 28 |
| MPM ASSET MANAGEMENT INVESTORS BV5 LLC | Venture Capital Fund | $1.9M | $0.0M | 22 |
| MPM ASSET MANAGEMENT INVESTORS BV2014 LLC | Venture Capital Fund | $6.7M | $0.0M | 26 |
| MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Venture Capital Fund | $13.6M | $0.0M | 24 |
| MPM BIO 2014 NVS STRATEGIC FUND, L.P. | Venture Capital Fund | $7.2M | $0.1M | 2 |
| MPM BIO IV NVS STRATEGIC FUND, L.P. | Venture Capital Fund | $7.3M | $100.0M | 2 |
| MPM BIO V NVS STRATEGIC FUND, L.P. | Venture Capital Fund | $5.1M | $0.1M | 2 |
| MPM BIOVENTURES 2014 (B), L.P. | Venture Capital Fund | $9.7M | $0.1M | 13 |
| MPM BIOVENTURES 2014, L.P. | Venture Capital Fund | $147.7M | $0.1M | 61 |
| MPM BIOVENTURES 2018 (B), L.P. | Venture Capital Fund | $33.9M | $0.2M | 8 |
| MPM BIOVENTURES 2018, L.P. | Venture Capital Fund | $652.6M | $0.1M | 43 |
| MPM BIOVENTURES 2022, L.P. | Private Equity Fund | $345.5M | $3.0M | 40 |
| MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG | Venture Capital Fund | $1.6M | $15.0M | 2 |
| MPM BIOVENTURES IV-QP, L.P. | Venture Capital Fund | $52.5M | $0.1M | 68 |
| MPM BIOVENTURES V, L.P. | Venture Capital Fund | $20.4M | $0.1M | 29 |
| MPM ONCOLOGY INNOVATIONS FUND L.P. | Venture Capital Fund | $169.9M | $0.3M | 36 |
| ONCOLOGY IMPACT FUND 2, L.P. | HEDGE FUND AND VENTURE CAPITAL | $826.0M | $5.0M | 32 |
| ONCOLOGY INVESTORS OF TEXAS COSTIM, LLC | Venture Capital Fund | $0.9M | $0.1M | 8 |
| UBS ONCOLOGY IMPACT FUND L.P. | HEDGE FUND AND VENTURE CAPITAL | $721.0M | $5.0M | 660 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| GADICKE, ANSBERT, K | Individual | – | MANAGING DIRECTOR | 11/2015 | 25-50% |
| EVNIN, LUKE, BASIL | Individual | – | SENIOR ADVISOR | 01/2024 | < 5% |
| MPM CAPITAL LLC | Domestic Entity | – | MEMBER | 11/2015 | 50-75% |
| MPM FOUNDERS LLC | Domestic Entity | MPM CAPITAL LLC | MEMBER | 12/1999 | > 75% |
| EVNIN, LUKE, BASIL | Individual | MPM FOUNDERS LLC | MEMBER | 12/1999 | 50-75% |
| FOLEY, TODD | Individual | – | MANAGING DIRECTOR | 11/2015 | < 5% |
| GADICKE 2012 IRREVOCABLE TRUST | Domestic Entity | MPM FOUNDERS LLC | MEMBER | 11/2015 | 25-50% |
| LAGUERRE, KRISTEN, LEE | Individual | – | PARTNER, FINANCE AND OPERATIONS | 10/2019 | < 5% |
| ANSBERT K. GADICKE 2015 IRREVOCABLE TRUST II | Domestic Entity | MPM FOUNDERS LLC | MEMBER | 11/2015 | 25-50% |
| GADICKE, ANSBERT, K | Individual | GADICKE 2012 IRREVOCABLE TRUST | TRUSTEE | 01/2012 | |
| KARGER, PAUL | Individual | ANSBERT K. GADICKE 2015 IRREVOCABLE TRUST II | TRUSTEE | 01/2015 | |
| BARDON, CHRISTIANA, GOH | Individual | ANSBERT K. GADICKE 2015 IRREVOCABLE TRUST II | TRUSTEE | 11/2015 | |
| Furey, Brendan, Michael | Individual | – | CHIEF COMPLIANCE OFFICER | 11/2022 | < 5% |
| Risoleo, Robert, Samuel | Individual | – | GENERAL COUNSEL | 01/2024 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
| Name | Class | Value $USD | # Shares | Private Fund |
|---|---|---|---|---|
| Adaptimmune Therapeutics plc | Sponsored ADR | 5M | 6M | – |
| Dyne Therapeutics, Inc. | Common | 55M | 2M | – |
| Entrada Therapeutics, Inc. | Common | 63M | 4M | – |
| iTeos Therapeutics, Inc. | Common | 41M | 3M | – |
| Repare Therapeutics, Inc. | Common | 7M | 2M | – |
| Werewolf Therapeutics, Inc. | Common | 10M | 4M | – |